NZ183157A - Disodium cromoglycate containing less than 5 percent of water compositions - Google Patents

Disodium cromoglycate containing less than 5 percent of water compositions

Info

Publication number
NZ183157A
NZ183157A NZ183157A NZ18315777A NZ183157A NZ 183157 A NZ183157 A NZ 183157A NZ 183157 A NZ183157 A NZ 183157A NZ 18315777 A NZ18315777 A NZ 18315777A NZ 183157 A NZ183157 A NZ 183157A
Authority
NZ
New Zealand
Prior art keywords
percent
containing less
water compositions
disodium cromoglycate
cromoglycate containing
Prior art date
Application number
NZ183157A
Other languages
English (en)
Inventor
C Booles
K Brown
Wf Kirk
Na Stevenson
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26238506&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ183157(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB3672/76A external-priority patent/GB1562901A/en
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of NZ183157A publication Critical patent/NZ183157A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Cosmetics (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ183157A 1976-01-30 1977-01-25 Disodium cromoglycate containing less than 5 percent of water compositions NZ183157A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3672/76A GB1562901A (en) 1976-01-30 1976-01-30 Disodium cromoglycate
GB5113676 1976-12-08

Publications (1)

Publication Number Publication Date
NZ183157A true NZ183157A (en) 1979-08-31

Family

ID=26238506

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ183157A NZ183157A (en) 1976-01-30 1977-01-25 Disodium cromoglycate containing less than 5 percent of water compositions

Country Status (14)

Country Link
JP (1) JPS5294411A (enrdf_load_stackoverflow)
AU (1) AU512593B2 (enrdf_load_stackoverflow)
DE (1) DE2703119A1 (enrdf_load_stackoverflow)
DK (2) DK154766C (enrdf_load_stackoverflow)
ES (1) ES455478A1 (enrdf_load_stackoverflow)
FI (1) FI770215A7 (enrdf_load_stackoverflow)
FR (1) FR2339604A1 (enrdf_load_stackoverflow)
IE (1) IE44760B1 (enrdf_load_stackoverflow)
IL (1) IL51314A (enrdf_load_stackoverflow)
LU (1) LU76661A1 (enrdf_load_stackoverflow)
NL (1) NL185446C (enrdf_load_stackoverflow)
NO (2) NO151860C (enrdf_load_stackoverflow)
NZ (1) NZ183157A (enrdf_load_stackoverflow)
SE (2) SE442268B (enrdf_load_stackoverflow)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU522792B2 (en) * 1977-07-19 1982-06-24 Fisons Plc Pressure pack formulation
GB2077100B (en) * 1980-04-30 1985-04-24 Fisons Ltd Pharmaceutical compositions containing cromoglycates
ZA812811B (en) * 1980-04-30 1982-06-30 Fisons Ltd Mixtures and salts of beta-2 selective bronchodilators with cromoglycic acid and salts thereof
JPS63138228U (enrdf_load_stackoverflow) * 1987-03-05 1988-09-12
JPS63138229U (enrdf_load_stackoverflow) * 1987-03-05 1988-09-12
DE68915203T2 (de) * 1988-03-22 1994-09-22 Fisons Plc, Ipswich, Suffolk Pharmazeutische Mischungen.
GB8819490D0 (en) * 1988-08-16 1988-09-21 Fisons Plc Pharmaceutical devices
GB8829478D0 (en) * 1988-12-16 1989-02-01 Harris Pharma Ltd Formulations
DE4003270A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
ATE128350T1 (de) * 1991-12-12 1995-10-15 Glaxo Group Ltd Pharmazeutische aerosolformulierung.
US5916540A (en) * 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
DK0616524T3 (da) 1991-12-12 1999-06-21 Glaxo Group Ltd Lægemidler
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
ATE150296T1 (de) 1991-12-18 1997-04-15 Minnesota Mining & Mfg Aerosolzusammensetzungen für arzneimittelsuspensionen
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
CA2338753C (en) 1998-07-24 2006-11-21 Jago Research Ag Medicinal aerosol formulations
ES2193726T3 (es) * 1998-08-04 2003-11-01 Jago Res Ag Formulaciones de aerosol medicinales.
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
PL2425820T3 (pl) 2007-02-11 2015-08-31 Map Pharmaceuticals Inc Sposób terapeutycznego stosowania dhe w celu umożliwienia szybkiego złagodzenia migreny przy jednoczesnym zminimalizowaniu profilu działań niepożądanych
CN116509836A (zh) * 2023-03-23 2023-08-01 中山万汉制药有限公司 色甘酸钠－季铵盐复合物及其制备方法与用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE555319A (enrdf_load_stackoverflow) * 1956-03-21 1900-01-01
BE556587A (enrdf_load_stackoverflow) * 1957-01-31 1957-04-11
GB1063512A (en) * 1962-11-30 1967-03-30 Benger Lab Ltd Aerosols
US3282791A (en) * 1965-08-17 1966-11-01 Merck & Co Inc Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
IL44022A0 (en) * 1973-01-23 1974-05-16 Fisons Ltd Novel salts of anti-inflammatory quinoline derivatives,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
SE8107278L (sv) 1981-12-04
SE442268B (sv) 1985-12-16
DE2703119C2 (enrdf_load_stackoverflow) 1990-10-25
NO770286L (no) 1977-08-02
IE44760L (en) 1977-07-30
SE442267B (sv) 1985-12-16
NL185446B (nl) 1989-11-16
FI770215A7 (enrdf_load_stackoverflow) 1977-07-31
ES455478A1 (es) 1978-02-01
IL51314A0 (en) 1977-03-31
DK357588A (da) 1988-06-29
NL185446C (nl) 1990-04-17
SE7700888L (sv) 1977-07-31
IL51314A (en) 1980-03-31
FR2339604B1 (enrdf_load_stackoverflow) 1980-12-05
FR2339604A1 (fr) 1977-08-26
DK154766C (da) 1989-05-22
LU76661A1 (enrdf_load_stackoverflow) 1977-08-03
IE44760B1 (en) 1982-03-24
NO151860B (no) 1985-03-11
NO780183L (no) 1977-08-02
DE2703119A1 (de) 1977-08-04
AU2162677A (en) 1978-08-03
DK156876B (da) 1989-10-16
DK156876C (da) 1990-03-12
DK357588D0 (da) 1988-06-29
NL7700911A (nl) 1977-08-02
JPS6129929B2 (enrdf_load_stackoverflow) 1986-07-10
DK38077A (da) 1977-07-31
NO151860C (no) 1985-06-19
AU512593B2 (en) 1980-10-16
DK154766B (da) 1988-12-19
JPS5294411A (en) 1977-08-09

Similar Documents

Publication Publication Date Title
NZ183157A (en) Disodium cromoglycate containing less than 5 percent of water compositions
GB2020550B (en) Compositions containing acyl carnitines
JPS5569598A (en) Manufacture of 4*66dii00*aminoglycosyl**1*33 diaminocyclitols
JPS52153964A (en) Preparation of benzimidazolonee*2*
PT66161B (en) Novel composition of matter
JPS54122287A (en) Manufacture of 33hydroxyy66phenyll1*2*3*44 tetrahydroo1*55benzodiazosin
JPS54163532A (en) Manufacture of 2*66dialkyllnnalkylaniline
JPS54109977A (en) Manufacture of 1*2*44triazole
JPS54148716A (en) Manufacture of 33hydroxyy2*2*44trimethyll pentylisobutyrate
JPS5519274A (en) Manufacture of 1*77octadiene
JPS5323974A (en) Preparation of 55aminoo1*2*33thiadiazole
JPS5555161A (en) Intermediate for manufacture of 1*55disubstitutedd22pyrrolidones
JPS5519275A (en) Manufacture of 1*77octadiene
JPS52139155A (en) Compositions of high molecular compounds stabilized
JPS54154703A (en) Manufacture of 1*22dichloroethane
JPS5553226A (en) Manufacture of 2*33dimethyll2*33butanediol
JPS54130505A (en) Manufacture of 1*77octadiene
JPS54157585A (en) Manufacture of 1*44benzodiazepin
JPS5346974A (en) Preparation of thiazolinee*3*
JPS5293777A (en) Preparation of 1*22benzothiadinee33carboxyamide
JPS54122244A (en) Manufacture of 1*22dioxime
JPS52116485A (en) Preparation of 33phenylpyridazonee*6*
JPS54128569A (en) Manufacture of 22*2*22dimethyll33butenee11yl** 22oxazolin
JPS5559118A (en) Manufacture of 1*11difluoroo22chloroethylene
JPS5535099A (en) Manufacture of 5*66dihydroo22methyllnnphenyll 1*44oxathiinn33carboxamide